A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction

Metformin improves cardiovascular prognosis in patients with diabetes mellitus, compared to alternative glucose-lowering drugs, despite similar glycemic control. Direct cardiovascular protective properties have therefore been proposed, and studied in preclinical models of myocardial infarction. We n...

Descripción completa

Detalles Bibliográficos
Autores principales: Hesen, Nienke A., Riksen, Niels P., Aalders, Bart, Ritskes-Hoitinga, Merel, El Messaoudi, Saloua, Wever, Kimberley E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568412/
https://www.ncbi.nlm.nih.gov/pubmed/28832637
http://dx.doi.org/10.1371/journal.pone.0183664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568412/
https://www.ncbi.nlm.nih.gov/pubmed/28832637
http://dx.doi.org/10.1371/journal.pone.0183664

Ejemplares similares